Episode Details

Back to Episodes
Why Prescribed Stimulant Withdrawal Stays Unstudied

Why Prescribed Stimulant Withdrawal Stays Unstudied

Episode 6527 Published 4 days, 19 hours ago
Description
Immediate-release stimulants clear the body within hours, but the neurochemical adaptations built around daily dosing can linger for weeks. Despite clear label warnings for fatigue, dysphoria, and sleep disruption upon cessation, medicine treats therapeutic stimulant discontinuation as negligible compared to SSRIs. Exploring the pharmacokinetics of methylphenidate, prodrug ramps like lisdexamfetamine, and the lack of research tracking everyday prescription patients reveals a profound blind spot in ADHD pharmacology. Episode 6527 — myweirdprompts.com/n/6527 (permanent short link: myweirdprompts.com/958254) Listen on Android: MWP FM Player — myweirdprompts.com/apk
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us